Mexico - Latin America Influenza Vaccine Market Size & Outlook

Name: Mexico - Latin America Influenza Vaccine Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The influenza vaccine market in Mexico - Latin America is expected to reach a projected revenue of US$ 85.4 million by 2030. A compound annual growth rate of 7.8% is expected of Mexico - Latin America influenza vaccine market from 2024 to 2030.

Pharmaceuticals
- Vaccines
  - Influenza Vaccine Market Outlook

Mexico influenza vaccine vaccine type outlook (Revenue, USD million, 2018-2030)
- Inactivated
- Live Attenuated
Mexico influenza vaccine indication outlook (Revenue, USD million, 2018-2030)
- Quadrivalent
- Trivalent
Mexico influenza vaccine age group outlook (Revenue, USD million, 2018-2030)
- Pediatric
- Adult
Mexico influenza vaccine route of administration outlook (Revenue, USD million, 2018-2030)
- Injection
- Nasal Spray
Mexico influenza vaccine distribution channel outlook (Revenue, USD million, 2018-2030)
- Hospitals & Pharmacy
- Government & Institutional supply
- Other Distribution Channels

Mexico - Latin America Influenza Vaccine Market Size & Outlook

Data Tree

Sign up - it's easy, and free!